Skip to main navigation
Stoke Therapeutics
  • Join Our Team
  • Contact Us
  • About Us
    • Leadership
    • Board of Directors
    • Scientific Advisory Board
    • COVID-19 Statement
    • Racial Equity
  • Our Story
  • Our Science
  • Our Work in Dravet
  • Our Pipeline
  • Investors & Media
    • Overview
    • Media Room
    • Press Releases
    • Events & Presentations
    • Financials & SEC Filings
    • Stock Information
    • Analyst Coverage
    • Governance

SEC Filing Details

SEC Filing Details

Document Details

Form
4
Filing Date
January 4, 2021
Document Date
December 30, 2020
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Stoke Therapeutics
Issuer
Stoke Therapeutics, Inc.
Filer
Kaye Edward M. MD

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS

Toolkit

Print Page
Email Alerts
Contact IR
FAQ
© 2021 Stoke Therapeutics,
all rights reserved.
  • Terms of Use
  • Privacy Policy
  • Home
  • About Us
      « Back
    • Leadership
    • Board of Directors
    • Scientific Advisory Board
    • COVID-19 Statement
    • Racial Equity
  • Our Story
  • Our Science
  • Our Work in Dravet
  • Our Pipeline
  • Investors & Media
      « Back
    • Overview
    • Media Room
    • Press Releases
    • Events & Presentations
    • Financials & SEC Filings
    • Stock Information
    • Analyst Coverage
    • Governance
  • Join Our Team
  • Contact Us